These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis. Pelletier MP; Edwardes MD; Michel RP; Halwani F; Morin JE Can J Surg; 2001 Jun; 44(3):180-8. PubMed ID: 11407827 [TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of Deoxyribonucleic acid (DNA) image analysis cytometry and immunohistochemical expression of Ki67 in surgically resected non-small cell lung cancers. Maounis NF; Chorti M; Apostolakis E; Ellina E; Blana A; Aggelidou M; Dritsas I; Markidou S Cancer Detect Prev; 2006; 30(6):507-14. PubMed ID: 17113721 [TBL] [Abstract][Full Text] [Related]
4. Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer ? A multivariate prognostic factor analysis of 151 patients. Ichinose Y; Hara N; Ohta M; Yano T; Maeda K; Asoh H; Katsuda Y J Thorac Cardiovasc Surg; 1993 Jul; 106(1):90-4. PubMed ID: 8391613 [TBL] [Abstract][Full Text] [Related]
5. [Contribution of flow cytometry in the prognostic evaluation of non-small-cell lung cancers. Review of the literature]. Jeanfaivre T; Chassevent A; Larra F; Tuchais E Bull Cancer; 1994 Jul; 81(7):605-9. PubMed ID: 7742603 [TBL] [Abstract][Full Text] [Related]
6. [The prognostic significance of nuclear DNA content in non-small-cell lung carcinoma]. Yamaoka N; Uchiyama Y; Kimino K; Akamine S; Matsuo S; Tsuji K Nihon Geka Gakkai Zasshi; 1990 Oct; 91(10):1608-16. PubMed ID: 2175839 [TBL] [Abstract][Full Text] [Related]
7. Stratification of the biologic aggressiveness of non-small cell lung cancer using DNA flow cytometry and immunohistochemistry for the retinoblastoma protein. Otsuka H; Funai S; Tanaka A; Hara S; Shiozaki H Lung Cancer; 2004 Sep; 45(3):307-16. PubMed ID: 15301871 [TBL] [Abstract][Full Text] [Related]
8. [Flow cytometric analysis of the DNA content of resected non-small cell lung cancer with reference to long-term follow-up]. Nagai S; Chiba W; Ikeda S; Matsumoto H; Fujimoto T; Ishida H; Wazawa H; Hanawa T; Yamashita N; Yasuda Y; Matsubara Y; Hatakenaka R; Funatsu T Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():130-4. PubMed ID: 8678555 [TBL] [Abstract][Full Text] [Related]
9. Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer. Graziano SL; Tatum AH; Gonchoroff NJ; Newman NB; Kohman LJ Clin Cancer Res; 1997 Jan; 3(1):87-93. PubMed ID: 9815542 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of deoxyribonucleic acid aneuploidy in primary non-small-cell lung carcinomas and their metastases. Liewald F; Hatz R; Storck M; Orend KH; Weiss M; Wulf G; Valet G; Sunder-Plassmann L J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1476-82. PubMed ID: 1331622 [TBL] [Abstract][Full Text] [Related]
13. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification]. Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272 [TBL] [Abstract][Full Text] [Related]
14. [Flow cytometric analysis in non-small-cell bronchial carcinoma and its prognostic significance]. Liewald F; Sunder-Plassmann L; Valet G; Wulf G; Weiss M; Schildberg FW Chirurg; 1992 Mar; 63(3):205-10. PubMed ID: 1313755 [TBL] [Abstract][Full Text] [Related]
15. Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma. Volm M; Hahn EW; Mattern J; Müller T; Vogt-Moykopf I; Weber E Cancer Res; 1988 May; 48(10):2923-8. PubMed ID: 2834052 [TBL] [Abstract][Full Text] [Related]
16. [Studies on flow cytometric analysis of nuclear DNA content in non-small cell lung cancer]. Isobe H Hokkaido Igaku Zasshi; 1991 Jan; 66(1):49-58. PubMed ID: 1848524 [TBL] [Abstract][Full Text] [Related]
17. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer. De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer. Miyamoto H; Harada M; Isobe H; Akita HD; Haneda H; Yamaguchi E; Kuzumaki N; Kawakami Y Cancer Res; 1991 Dec; 51(23 Pt 1):6346-50. PubMed ID: 1657384 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era. Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry. Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]